A Long-term Safety Study of Infliximab (Remicade)

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study evaluating the long-term safety of infliximab (Remicade)

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centocor, Inc.
• Collaborator: Centocor BV
• Treatments: Infliximab

Criteria

Inclusion Criteria:

• All patients enrolled in ongoing and future Centocor sponsored infliximab clinical studies that require long-term safety follow-up (ie, primary studies). Patients must have received at least 1 dose of study agent to be eligible for participation in the study

Exclusion Criteria:

• Did not previously participate in Centocor sponsored infliximab clinical studies.